These novel medications , Semaglutide , represent a groundbreaking advancement in managing obesity and potentially other conditions . These drugs are categorized as GLP-1 hormone agonists , indicating https://minascey910525.luwebs.com/42474111/semaglutide-a-thorough-dive-into-incretin-copyright